Chargement en cours...
Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial
Background. An exploratory subanalysis of the ODIN trial was performed to evaluate the efficacy of darunavir/ritonavir (DRV/r) 800/100 mg OD versus 600/100 mg BID in patients who were NNRTI-experienced but PI-naïve. Methods. ODIN was a phase III, 48-week study comparing DRV/r OD versus BID in 590 tr...
Enregistré dans:
| Publié dans: | AIDS Res Treat |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4555450/ https://ncbi.nlm.nih.gov/pubmed/26357568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/962574 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|